Assessment of the Antitumor Potential of Bithionol in Vivo Using a Xenograft Model of Ovarian Cancer

Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000364
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

A Risk Assessment of a Common Drug Using Xenograft Model

Annals of Translational Medicine
Medicine
2017English

Antitumor Activity of Celastrol Nanoparticles in a Xenograft Retinoblastoma Tumor Model

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2012English

Evaluation of the Cytotoxicity of the Bithionol-Paclitaxel Combination in a Panel of Human Ovarian Cancer Cell Lines

PLoS ONE
Multidisciplinary
2017English

Antitumor Mechanism of Gold Nanoparticles in Ovarian Cancer

Science-Business eXchange
2013English

Antitumor Effect of Combined NAMPT and CD73 Inhibition in an Ovarian Cancer Model

Oncotarget
Oncology
2015English

Antitumor Effects of Flavopiridol on Human Uterine Leiomyoma in Vitro and in a Xenograft Model

Reproductive Sciences
GynecologyObstetrics
2014English

Patient-Derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2019English

Antitumor Effects of a Human Dimeric Antibody Fragment 131i-Afra-Dfm5.3 in a Mouse Model for Ovarian Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

The Progress of Antitumor Interstitial Treatment Strategy of Malignant Ovarian Cancer

Asian Case Reports in Obstetrics and Gynecology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy